BIONIK Laboratories Corp launches its newest generation InMotion ARM/HAND robotic system for clinical rehabilitation of stroke survivors and those with mobility impairments due to neurological conditions.
The new technology, which made its official debut recently at the American Physical Therapy Association Combined Sections Meeting (APTA CSM) in Washington, DC, includes the following new features, according to the Toronto-based company:
- Enhanced hand-rehabilitation technology: provides therapy focused on hand opening and grasping for patients ready to retrain reach and grasp functional tasks.
- InMotion EVAL: assesses hand movements precisely and objectively, allowing clinicians to better measure and quantify patient progress.
- Improved, comprehensive reporting: improved documentation of patient outcomes, easier use and enhanced interpretation of evaluation results, allowing clearer progress indications over the complete rehabilitation journey, all on one screen.
“The goal of our new generation InMotion ARM/HAND is to enable rehabilitation facilities to enhance their treatment programs for patients recovering from stroke or other neurological injury who are ready to retrain reach and grasp functionality. Along with the improved reporting capabilities, we believe our innovative technology will enable clinicians to improve the patient rehabilitation process and achieve greater recovery for stroke survivors,” says Dr Eric Dusseux, CEO, BIONIK Laboratories, in a media release.
“We’re pleased to unveil the new generation InMotion ARM/HAND at APTA CSM and to showcase its functionality to some of the leading minds in physical therapy,” he adds.
[Source(s): BIONIK Laboratories Corp, Business Wire]